Nafithromycin: advancements in antibiotic therapy against community-acquired pneumonia-resistant pathogens
Nafithromycin (WCK 4873) is a novel lactone ketolide antibiotic developed to address the critical issue of multidrug-resistant bacteria, especially those causing community-acquired pneumonia (CAP). Given the increasing prevalence of antibiotic resistance, there is a pressing need for new antibiotic...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
PAGEPress Publications
2025-08-01
|
| Rangatū: | Monaldi Archives for Chest Disease |
| Ngā marau: | |
| Urunga tuihono: | https://www.monaldi-archives.org/macd/article/view/3340 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|